| Novartis Pharma Schweiz AG - Beovu 120mg/1ml, Injektionslösung in Fertigspritze |
| 67244 | | 01 | | Beovu 120mg/1ml | | Injektionslösung in Fertigspritze | | S01LA06 | | Brolucizumab | | 16.01.2020 | | |
|
| Composition |
| brolucizumabum 120 mg, saccharum, natrii citras anhydricus, polysorbatum 80, natrii hydroxidum, aqua ad iniectabile, ad solutionem pro 1 ml. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Brolucizumabum | 120 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Brolucizumabum | 120 mg |
| | | | Inactive agents |
|---|
| Natrii Citras Anhydricus | | Sodium Hydroxide | | Polysorbatum 80 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 652.91 | 726.50 | B | SL | No |
|
